HealthCor Management L.P. acquired a new stake in Iqvia Holdings Inc (NYSE:IQV) in the 4th quarter, Holdings Channel reports. The institutional investor acquired 783,380 shares of the medical research company’s stock, valued at approximately $76,693,000. Iqvia makes up about 2.5% of HealthCor Management L.P.’s holdings, making the stock its 17th largest position.
Other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. bought a new position in shares of Iqvia during the fourth quarter valued at approximately $942,532,000. Longview Partners Guernsey LTD bought a new position in shares of Iqvia during the fourth quarter valued at approximately $927,548,000. Jackson Square Partners LLC bought a new position in shares of Iqvia during the fourth quarter valued at approximately $464,053,000. Farallon Capital Management LLC bought a new position in shares of Iqvia during the fourth quarter valued at approximately $290,072,000. Finally, Alliancebernstein L.P. bought a new position in shares of Iqvia during the fourth quarter valued at approximately $253,128,000. 92.34% of the stock is owned by hedge funds and other institutional investors.
IQV has been the subject of several recent research reports. TheStreet raised Iqvia from a “c+” rating to a “b” rating in a report on Wednesday, December 13th. SunTrust Banks raised Iqvia from a “hold” rating to a “buy” rating in a report on Wednesday, March 7th. ValuEngine raised Iqvia from a “hold” rating to a “buy” rating in a report on Tuesday, February 20th. Zacks Investment Research raised Iqvia from a “hold” rating to a “buy” rating and set a $112.00 target price for the company in a report on Thursday, January 18th. Finally, Royal Bank of Canada set a $118.00 target price on Iqvia and gave the company a “buy” rating in a report on Thursday, February 15th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $110.02.
Iqvia (NYSE:IQV) last issued its quarterly earnings data on Wednesday, February 14th. The medical research company reported $1.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.34 by ($0.02). Iqvia had a return on equity of 13.03% and a net margin of 13.44%. The business had revenue of $2.16 billion during the quarter, compared to the consensus estimate of $2.14 billion. During the same period last year, the company earned $1.09 earnings per share. The business’s quarterly revenue was up 10.7% compared to the same quarter last year. analysts anticipate that Iqvia Holdings Inc will post 2.84 earnings per share for the current fiscal year.
In other Iqvia news, Director Michael J. Evanisko sold 816 shares of the company’s stock in a transaction that occurred on Monday, March 5th. The stock was sold at an average price of $100.00, for a total value of $81,600.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider James H. Erlinger III sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, January 17th. The stock was sold at an average price of $99.97, for a total value of $999,700.00. The disclosure for this sale can be found here. Insiders sold 30,816 shares of company stock valued at $3,093,400 over the last 90 days. 6.00% of the stock is currently owned by insiders.
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Iqvia Holdings Inc (NYSE:IQV).
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.